Coloplast A/S (CBHD) Stock Statistics & Valuation Metrics

Coloplast A/S has a market cap or net worth of CHF12.17B. The enterprise value is CHF121.51K.

Coloplast A/S has 210,200,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Coloplast A/S’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 10.07%.

The current PE Ratio of Coloplast A/S is 46.6. Coloplast A/S’s PEG ratio is ―.

In the last 12 months, Coloplast A/S had revenue of 27.87B and earned 3.64B in profits. Earnings per share was 16.13.

In the last 12 months, operating cash flow was 7.59B and capital expenditures -1.56B, giving a free cash flow of 6.03B billion.

Coloplast A/S pays an annual dividend of ―, resulting in a dividend yield of ―

Coloplast A/S upcoming earnings date is Aug 18, 2026, TBA (Confirmed).

Coloplast A/S as a current ratio of 1.61, with Debt / Equity ratio of 188.65%

In the past 12 months, Coloplast A/S has paid 2.52B in taxes.

Coloplast A/S EV to EBITDA ratio is 17.28, with an EV/FCF ratio of 26.98.

Coloplast A/S has CHF1.07B in cash and marketable securities with CHF24.26B in debt, giving a net cash position of -CHF23.16B billion.

Gross margin is 58.60%, with operating margin of 27.19%, and net profit margin of 13.04%.

The average price target for Coloplast A/S is CHF63.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy